Patient-derived organoids for personalized gallbladder cancer modelling and drug screening.
Bo YuanXiaofang ZhaoXiang WangErdong LiuChunliang LiuYali ZongYouhai JiangMinghui HouYao ChenLei ChenYongjie ZhangHong-Yang WangJing FuPublished in: Clinical and translational medicine (2022)
Patient-derived organoids are potentially a useful platform to explore molecular pathogenesis of gallbladder tumours and discover personalized drugs.